Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was granted accelerated approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults with NASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) and is being studied in a Phase 3 trial for the treatment of NASH with compensated cirrhosis. The Thought Leader Liaison (TLL) at Madrigal Pharmaceuticals is a commercial role as a dynamic leader with deep customer knowledge and passion to exceed organizational success. This position focuses on building and fostering strong partnerships with Thought Leaders in academic and clinical medicine to support the launch of Resmetirom, a ground-breaking therapy for Metabolic Associated Steatohepatitis (MASH). As a TLL, you'll play a key role in executing brand and disease-state strategies through impactful Thought Leader engagement, generating Brand and Market Insights, and contributing to the management of Commercial Speaker Bureau. You'll collaborate across functions and contribute to achieving common goals while acting as a trusted resource and partner. Reporting to the Director of Thought Leader Liaisons, this role provides an opportunity to combine your exceptional communication skills and expertise in field marketing with a commitment to advancing education, advocacy and patient care in MASH. As with all employees, Thought Leader Liaisons are fully accountable for compliance with all laws, regulations, and policies that govern the conduct of Madrigal activities.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Industry
Chemical Manufacturing
Education Level
Bachelor's degree